Trials / Completed
CompletedNCT01899248
The Effect of Inhalation Agent on the QTc Interval During Liver Transplantation: Sub Study (NCT01886664)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 52 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the effects of inhalation agent on corrected QT interval duration during liver transplantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sevoflurane | |
| DRUG | Desflurane |
Timeline
- Start date
- 2012-12-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2013-07-15
- Last updated
- 2014-05-14
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01899248. Inclusion in this directory is not an endorsement.